Burnet Institute

Around 5–10% of people with COVID infections go on to experience #longCOVID, with symptoms lasting three months or more. Around 5–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more. Researchers have proposed several biological mechanisms to explain long COVID. However, in a perspective article published in the latest Medical Journal of Australia, Burnet researchers argue that much, if not all, long COVID appears to be driven by the virus itself persisting in the body. Read what the science says about how long COVID appears to be driven by "long infection" on The Conversation Australia + NZ here: https://lnkd.in/gxdjQNmz Written by Burnet director and CEO Prof Brendan Crabb AC, theme leader of Antiviral Immunity Dr Gabriela Khoury and senior research fellow Dr Michelle Scoullar.

Burnet celebrated our most significant annual awards, the Gust-McKenzie Medal and the Frank Fenner Award this month. Congratulations to: Dr. Julie Hennegan, senior research fellow and co-head of the Global Adolescent Health working group on receiving the Gust-McKenzie Medal — awarded to an outstanding mid-career staff member for excellence in research and public health and Dr Phone Myint Win, Burnet's country representative in Myanmar on receiving the Frank Fenner Award, which acknowledges the significant contribution to the Institute's vision and mission in medical research and public health, named after the late Australian virologist, Professor Frank Fenner AC. https://lnkd.in/gstyVfeQ #GlobalHealth #PublicHealth #MenstrualHealth #Leadership #HealthEquity

Burnet Institute was honoured to welcome Lady Primrose Potter AC to award the inaugural Lady Potter, Burnet Emerging Leader Fellowships to three outstanding researchers: Dr Fiona Angrisano, Dr Annie McDougall, and Dr Rachel Sacks-Davis. These fellowships, established through Lady Potter’s generous personal donation and Burnet's additional contribution, will provide each recipient with $250,000 to advance critical research in: - Malaria transmission-blocking vaccines - Pre-eclampsia prevention in maternal health - Hepatitis C elimination among people living with HIV Lady Potter is a renowned philanthropist and advocate for the arts, health, medicine, sciences and social causes in Australia. Her connection to Burnet spans decades, from comforting patients during the AIDS epidemic to advocating for improving global health. Read more: https://lnkd.in/g7fGSRW4 #Philanthropy #GlobalHealth #MedicalResearch #EmergingLeaders #MaternalHealth #MalariaPrevention #HepatitisCElimination #HealthEquity

Burnet acknowledges the important contribution of Troy Combo, program manager for the Eliminate Hepatitis C (EC) Australia Aboriginal Health Plan, and Dr Nicole Allard, senior clinical advisor at The Peter Doherty Institute for Infection and Immunity, in co-authoring the first-ever liver cancer chapter for the National Guide to Preventive Healthcare for Aboriginal and Torres Strait Islander People.   Liver cancer is often caused by viral hepatitis (B & C), alcoholic liver disease, and metabolic dysfunction-associated fatty liver disease. It typically occurs in a damaged liver, with cirrhosis as a significant risk factor.   Key highlights of the chapter include: - prevention strategies, which include hepatitis B vaccination, treatment for hepatitis B & C, and modifying health risk behaviours such as alcohol consumption and diet - the recommendation that testing for hepatitis B should be offered to all adult Aboriginal and Torres Strait Islander people whose immune status is unknown. Developed by NACCHO Australia in collaboration with The Royal Australian College of General Practitioners (RACGP), this fourth edition of the National Guide features greater involvement of Aboriginal and Torres Strait Islander authors and reviewers to ensure it aligns with community experiences and needs. https://lnkd.in/ga9Nv7FM

Applications for the Dorabjee Award close this Saturday 30 November. Apply here: https://lnkd.in/gxQKzZp9

Congratulations to Professor Sandra Eades AO, a member of Burnet's Board of Directors, on being selected as one of 15 advisers for the Lancet Global Health Commission on People-Centered Care for Universal Health Coverage (the Commission). Burnet principal research fellow Associate Professor Stephen Bell, PhD has also been selected as one of 34 commissioners for The Commission. "This esteemed group includes multidisciplinary experts from around the world representing people with lived experiences, health care providers, policymakers, academic researchers, civil society organizers, and private sector leaders," a statement from the Center for Primary Care at Harvard Medical School read. "Together, we are excited to embark on this important work to advance people-centered care globally, ensuring that health systems are designed and delivered for and with people, as we strive to achieve sustainable universal health coverage and health equity." More: https://lnkd.in/dNvXZYdi

The Burnext accelerator program removes funding barriers, which often limit researchers' ability to develop their ideas into real-world outcomes. It takes projects from proof-of-concept, through an intense process of milestone-driven project planning and delivery stages, to ensure outcomes within 24 months. Read more: https://lnkd.in/gPB2rhGf

On #WorldPrematurityDay, we reaffirm our commitment to reducing preterm births, in Australia and globally. We recognise the additional support mothers and their preterm or small babies need, and we're dedicated to advancing research in this area. Our Accelerating Innovation for Mothers (AIM) project is designed to encourage greater investment in research and development for pregnancy-specific conditions, including preterm labour and intrauterine growth restriction.   This is just one of the ways we are helping make a difference to mothers and their babies. https://lnkd.in/gSDX_RmD

Burnet director and CEO Prof Brendan Crabb AC, and CEOs across the Australian aid sector have called out for a #SaferWorldforAll. Read more on how you can make a difference 👇

Professor James Beeson, deputy director of Research Strategy and head of Burnet’s Malaria Immunity and Vaccines Group, has been awarded two grants from the Bill & Melinda Gates Foundation to drive the development of innovative malaria vaccines. The two related grants will fund the use of cutting-edge research technologies in multiple clinical studies in East Africa to identify antibodies that precisely target key #malaria proteins. “Using advanced immunology approaches and biostatistical modelling, we’ll uncover which antibody types and antigen combinations are most protective against malaria, helping prioritise targets for future malaria vaccine development,” Professor Beeson said. Read more: https://lnkd.in/g3PhVZpm #MalariaVaccine #VaccineDevelopment #LifeSciences #MalariaResearch #HealthEquity